Eugenol modulates cyclooxygenase-2 expression through the activation of nuclear factor kappa B in human osteoblasts

Because eugenol is a major component of root canal sealers and retrograde filling materials, its effects on periapical bone healing are therefore of concern. in this study, the effects of eugenol on the activation of nuclear factor kappa B (NF-kappa B) and the expression of cyclooxygenase-2 (COX-2) in human osteoblasts were investigated. The results showed that eugenol activated the nuclear translocation of NF-kappa B. In addition, COX-2 protein expression in osteoblasts was induced by eugenol in a dose-dependent manner. Furthermore, the eugenol-modulated COX-2 expression was inhibited by an NF-kappa B inhibitor, N-acetylcysteine. Taken together, eugenol might induce COX-2 expression through the activation of NF-kappa B in human osteoblasts. These results suggest that eugenol might be involved in periapical healing by impairing the functions of osteoblasts.